Blood clues may predict survival after cardiac arrest rescue

NCT ID NCT07113769

Recruiting now Knowledge-focused Sponsor: Central China Fuwai Hospital of Zhengzhou University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking for proteins, metabolites, and platelet changes in the blood that could predict whether a person will survive after receiving ECPR, a machine that takes over heart and lung function during cardiac arrest. Researchers will study blood samples from 130 adults aged 18-70 who have had a witnessed cardiac arrest and received CPR within 5 minutes. The goal is to find objective markers that help doctors decide who is most likely to benefit from this intensive treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which cardiac arrest patients are most likely to benefit from ECPR, leading to better survival and recovery.
What could go wrong: This is an early observational study with only 130 participants, so findings may not apply to all patients. The markers identified may not prove reliable in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARREST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC ARREST EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)

Contacts and locations

Locations

Fuwai Central China Cardiovascular Hospital
RECRUITING

Zhengzhou, Henan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.